The Danish drugmaker has offered $60 per share for California biotech Longboard, with the main asset in the deal bexicaserin, an oral, centrally acting serotonin 5-HT 2C receptor super-agonist in ...
Use of two separate pattern recognition receptor (PRR) agonists as adjuvants in vaccine formulations ... The CL413 adjuvant induced higher IgG-anti-preF (p = 0.051) (Figure 2C) and -anti-G levels (p = ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback